Background illustration for clinical trials search

Paid Clinical Trials Worcester

Discover 3,097 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia

for
Severe Aplastic Anemia
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Medical College of Wisconsin

Sex: All

Age: 3 - 70+

Code: NCT06517641

Phase2, Recruiting

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

for
Chronic Myelomonocytic Leukemia,
Location: Boston MA, Rochester MN, Tampa FL, Houston TX,
Sponsor: Solu Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06950034

Phase1, Recruiting

Epco, Zanu, Ritux for R/R FL or MZL

for
Follicular Lymphoma, Lymphoma, Non-Hodgkin Lymphoma,
Location: Boston MA, New York NY, Columbus OH
Sponsor: Reid Merryman, MD

Sex: All

Age: 18+

Code: NCT06563596

Phase2, Recruiting

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

for
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Location: Boston MA, North Dartmouth MA, Stony Brook NY,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT05943535

Phase3, Recruiting

A Prospective Study on the Role of Karl Storz Curved and Straight Fetoscopes (11508AAK and 11506AAK) for Fetoscopic Intrauterine Procedures

for
Fetal Conditions, Maternal; Procedure, Pregnancy Related,
Location: Boston MA
Sponsor: Boston Children's Hospital

Sex: Female

Age: 18 - 45

Code: NCT06056635

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

for
Lupus Erythematosus, Systemic
Location: Boston MA, New York NY, Syracuse NY, Chapel Hill NC,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70

Code: NCT06897930

Phase1, Phase2, Recruiting

Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma

for
Head and Neck Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT03875716

Recruiting

Omalizumab Weight-Based Dosing Efficacy Trial

for
Allergies, Food Allergy
Location: Boston MA, Chapel Hill NC, Dallas TX
Sponsor: Massachusetts General Hospital

Sex: All

Age: 1 - 55

Code: NCT06943534

Phase2, Recruiting

Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy

for
Deafness, Cochlear Hearing Loss
Location: Boston MA
Sponsor: Massachusetts Eye and Ear Infirmary

Sex: All

Age: 18 - 70+

Code: NCT06960616

Recruiting

Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

for
Kidney Cancer
Location: Boston MA, Lebanon NH, Bronx NY, Pittsburgh PA,
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT00301990

Phase2, Recruiting

Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma

for
Advanced NUT Carcinoma, Metastatic NUT Carcinoma,
Location: Boston MA, Pittsburgh PA, Houston TX, Los Angeles CA
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT05019716

Phase1, Phase2, Recruiting

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

for
Renal Cell Carcinoma
Location: Boston MA, Ann Arbor MI, Dallas TX, Houston TX,
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06053658

Phase2, Recruiting

Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

for
16P11.2 Deletion Syndrome, 16p11.2 Duplications,
Location: Boston MA, Lewisburg PA
Sponsor: Simons Searchlight

Sex: All

Age: 0+

Code: NCT01238250

Recruiting

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

for
Oligometastatic Prostate Cancer (OMPC)
Location: Boston MA, The Bronx NY, New York NY, Syracuse NY,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT05939414

Phase3, Recruiting

Myo-inositol During Pregnancy to Prevent Gestational Diabetes

for
Pregnancy Related
Location: Boston MA
Sponsor: Tufts Medical Center

Sex: Female

Age: 18 - 45

Code: NCT06575868

Recruiting

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Boston MA, Providence RI, Hartford CT, New Haven CT,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT04684368

Phase2, Recruiting

Effect of Vitamin D Status and Repletion on Postoperative Total Joint Arthroplasty Complications

for
Hip Arthropathy, Knee Arthropathy, Vitamin D Deficiency
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18+

Code: NCT04229368

Recruiting

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

for
Grade 2 Meningioma, Intracranial Meningioma
Location: Boston MA, Hartford CT, Sanford ME, Lebanon NH,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT03180268

Phase3, Recruiting

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, New York NY, Philadelphia PA, Fairfax VA,
Sponsor: Pyxis Oncology, Inc

Sex: All

Age: 18+

Code: NCT06795412

Phase1, Phase2, Recruiting

CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

for
Solid Tumors, GI Cancer
Location: Boston MA, Baltimore MD, Washington DC, Durham NC,
Sponsor: Curegenix Inc.

Sex: All

Age: 18+

Code: NCT02675946

Phase1, Recruiting